Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
310 GBX | +3.33% | +6.90% | +9.54% |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
04-26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.54% | 3.2B | |
+29.95% | 699B | |
+25.07% | 571B | |
-4.44% | 364B | |
+18.34% | 326B | |
+3.17% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.59% | 154B |
- Stock Market
- Equities
- HCM Stock
- News HUTCHMED (China) Limited
- Hutchmed Starts Late-Stage Autoimmune Drug Trial in China